Operating Margin (Quarterly)

Operating Margin: Operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc. Calculated as: Operating Income / Total Revenues

Pfizer Inc. (PFE) had Operating Margin of 27.57% for the most recently reported fiscal quarter, ending 2024-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2024-03-31

Income Statement Financials
Revenue	$14.88B
Net Income	$3.12B
Cost of Goods Sold	$3.38B
Gross Profit	$11.50B
Operating Expenses	$10.78B
Operating Income	$4.10B
Non-Operating Income/Expense	$-680.00M
Pre-Tax Income	$3.42B
Normalized Pre-Tax Income	$3.42B
Income after Taxes	$3.13B
Income from Continuous Operations	$3.13B
Consolidated Net Income/Loss	$3.12B
Normalized Income after Taxes	$3.13B
EBIT	$4.10B
EBITDA	$5.84B
Weighted-Average Shares Outstanding (Basic)	5.66B
Weighted-Average Shares Outstanding (Diluted)	5.70B
Earnings per Share (EPS) (Basic)	$0.55
Earnings per Share (EPS) (Diluted)	$0.55
Balance Sheet Financials
Current Assets	$42.41B
Property, Plant, and Equipment	$18.80B
Long-Term Assets	$178.68B
Total Assets	$221.09B
Current Liabilities	$40.50B
Long-Term Debt	$61.31B
Long-Term Liabilities	$88.04B
Total Liabilities	$128.54B
Common Equity	$92.56B
Tangible Shareholders Equity	$-39.57B
Shareholders Equity	$92.56B
Common Shares Outstanding	5.67B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.09B
Cash Flow from Investing Activities	$1.73B
Cash Flow from Financial Activities	$-4.93B
Beginning Cash	$2.92B
End Cash	$780.00M
Increase/Decrease in Cash	$-2.14B
Stock-Based Compensation	$220.00M
Common Stock Dividends Paid	$-2.37B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.05
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.40
Debt to Equity Ratio	0.75
Gross Margin	77.29%
Operating Margin	27.57%
EBIT Margin	27.57%
EBITDA Margin	--
Pre-Tax Profit Margin	22.99%
Profit Margin	20.94%
Free Cash Flow	$386.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.07
Inventory Turnover	0.31
Receiveable Turnover	1.35
Days Sales in Receivables	66.47
Return on Equity	3.38%
Return on Tangible Equity	-7.91%
Return on Assets	1.41%
Return on Investments	2.03%
Book Value Per Share	$16.33
Free Cash Flow per Share	$0.07
Operating Cash Flow per Share	$0.19

Data from Zacks Investment Research, Inc.